文献速递冠心病

既往冠状动脉旁路移植术患者因急性冠脉综合征入院后的结局

Outcome of patients with prior coronary bypass surgery admitted with an acute coronary syndrome.
PubMed 文献 · Heart · 2021-01-18

两个时间段内抗血小板药、他汀和经皮介入使用均显著增加,30天MACE在两组均下降,但1年死亡率仅在无CABG史患者中下降,有CABG史者保持不变。

要点

  • 既往CABG的ACS患者占9.9%,更年老、合并症更多,多表现为NSTE-ACS。
  • 两个时间段内两组抗血小板、他汀和PCI使用均显著增加。
  • 有CABG史者30天MACE下降但1年死亡率未改善。

核心结论

  • 尽管近十年ACS管理和预后改善,既往CABG的ACS患者1年死亡率保持不变。

研究设计与样本

  • 对2000至2016年ACS以色列调查中注册的ACS患者进行时间依赖性分析,比较有或无既往CABG者,并分为早期(2000-2008)和晚期(2010-2016)两个时间段。

主要发现

  • 既往CABG患者更年老(69 vs 63岁),合并症更多,更多表现为非ST段抬高型ACS(82% vs 51%)。
  • 两个时间段内,两组抗血小板药、他汀和经皮介入使用均显著增加(每项p<0.001)。
  • 30天MACE在有既往CABG者中从19.1%降至12.4%(p=0.001),在无既往CABG者中从17.4%降至9.5%(p<0.001)。
  • 1年死亡率仅在无既往CABG者中下降(10.5% vs 7.4%,p<0.001),在有既往CABG者中保持不变。
  • 倾向性匹配后结果一致。

临床怎么用

  • 对既往CABG的ACS患者应关注其较高的合并症负担和NSTE-ACS表现。
  • 尽管二级预防和血运重建使用增加,仍需针对该人群探索改善长期预后的策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients with prior coronary artery bypass graft surgery (CABG) are at increased risk for recurrent cardiovascular ischaemic events. Advances in management have improved prognosis of patients with acute coronary syndrome (ACS), yet it is not known whether similar trends exist in patients with prior CABG. AIM: Examine temporal trends in the prevalence, treatment and clinical outcomes of patients with prior CABG admitted with ACS. METHODS: Time-dependent analysis of patients with or without prior CABG admitted with an ACS who enrolled in the ACS Israeli Surveys between 2000 and 2016. Surveys were divided into early (2000-2008) and late (2010-2016) time periods. Outcomes included 30 days major adverse cardiac events (30d MACE) (death, myocardial infarction, stroke, unstable angina, stent thrombosis, urgent revascularisation) and 1-year mortality. RESULTS: Among 15 152 patients with ACS, 1506 (9.9%) had a prior CABG. Patients with prior CABG were older (69 vs 63 years), had more comorbidities and presented more with non-ST elevation-ACS (82% vs 51%). Between time periods, utilisation of antiplatelets, statins and percutaneous interventions significantly increased in both groups (p<0.001 for each). The rate of 30d MACE decreased in patients with (19.1%-12.4%, p=0.001) and without (17.4%-9.5%, p<0.001) prior CABG. However, 1-year mortality decreased only in patients without prior CABG (10.5% vs 7.4%, p<0.001) and remained unchanged in patients with prior CABG. Results were consistent after propensity matching. CONCLUSIONS: Despite an improvement in the management and prognosis of patients with ACS in the last decade, the rate of 1-year mortality of patients with prior CABG admitted with an ACS remained unchanged.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Marcuschamer I, Zusman O, Iakobishvili Z, et al. Outcome of patients with prior coronary bypass surgery admitted with an acute coronary syndrome. Heart. 2021. PMID: 33462121. doi:10.1136/heartjnl-2020-318047

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。